impacthealthmr.com

What It Is

Based on the scraped page content, Impact Health Research Ltd appears to be a provider of market research and analytics services for the pharmaceutical industry. This page presents a case study on “price optimisation for a new psoriasis product.” The client was a pharmaceutical company looking to determine the optimal price before launching a new therapy—one that would be acceptable for formulary inclusion, complement the company’s existing product portfolio, and maximise commercial returns as far as possible.

Core Capabilities and Data Sources

The project centres on payer research and price optimisation. Impact Health collected frontline market access insights through in-depth telephone interviews with 20 UK CCG-level payers, each lasting around 45 minutes. Respondents included commissioners, prescribing advisers, medicines management personnel, health board pharmacists, GP leads, and members of AWMSG and SMC, with coverage across different UK regions. In terms of methodology, the page notes that costs for different dosage forms were standardised to enable clearer comparison, while Perceived Value Pricing and the Van Westendorp pricing method were used to assess acceptable price ranges.

Pricing, Platform, and Integrations

The public page does not disclose Impact Health’s own service pricing, billing model, project timelines, or whether it supports a subscription model. It therefore looks more like a project-based consulting/research service, although this cannot be confirmed from the text alone. The page also does not mention a SaaS platform, data dashboards, APIs, CRM integrations, or marketing automation integrations. As for support channels, the only confirmed research execution method is telephone interviews.

Pros and Cons

The strengths of this case are its clearly defined objective, with a focus on pharmaceutical pricing, formulary access, and competitor benchmarking. The interviewees are all professional roles related to UK market access, giving the sample a targeted structure. The methodology is also relatively professional, combining PVP with Van Westendorp to support more explainable pricing recommendations. The downside is that the public information is very limited: only a single case study is shown, with little detail on the company’s overall capabilities, deliverable examples, service workflow, pricing, or post-project support. There is also no sign of a self-service data product.

Best Fit and Access from China

This service is best suited to market access, pricing, commercialisation, and portfolio strategy teams at pharmaceutical companies, especially teams preparing to launch new drugs in the UK or in markets with similar payer systems. Access from China cannot be determined from the page content; network connectivity, cross-border payment, and contracting methods are not disclosed. Chinese teams looking for similar services may also want to evaluate healthcare market research firms such as IQVIA, Kantar Health, Ipsos Healthcare, and Research Partnership.